Angiotensin receptors and their therapeutic implications.
about
Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesionsPhysiology of kidney reninIntracellular Angiotensin II and cell growth of vascular smooth muscle cellsAngiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.Translational regulation of ANG II type 1 receptors in proliferating vascular smooth muscle cells.The effect of angiotensin II on intracellular pH is mediated by AT(1) receptor translocation.Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.Practical considerations of the pharmacology of angiotensin receptor blockers.AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling.The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension.Renin angiotensin system modulates mTOR pathway through AT2R in HIVANAngiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?Angiotensin II receptors and drug discovery in cardiovascular disease.Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophyCentral role of the AT(1)-receptor in atherosclerosis.Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxideDifferential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta.Construction of a yeast-based signaling biosensor for human angiotensin II type 1 receptor via functional coupling between Asn295-mutated receptor and Gpa1/Gi3 chimeric Gα.HIV-associated nephropathy: role of AT2R.Method Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry for Angiotensin-II in Human Plasma: Application to Study Interaction Between Atorvastatin & Olmesartan Drug CombinationInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen speciesInhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor.Candesartan: from left ventricular hypertrophy to heart failure, a global approach.Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartanCardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol.Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitorsAngiotensin type 2 receptors in the intermediolateral cell column of the spinal cord: negative regulation of sympathetic nerve activity and blood pressure.Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.Multifunctional actions of approved and candidate stroke drugs.Candesartan in the treatment of hypertension: what have we learnt in the last decade?Atherosclerosis and aortic aneurysm - is inflammation a common denominator?Further investigation of a quantitative trait locus for ascites on chromosome 9 in broiler chicken lines.Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes.Assesment of endocrinal and biochemical entities through liquid chromatography-tandem mass spectrometry/mass spectrometer: Inter-relative investigation of the interaction based cardiovascular formulationAt receptor inhibition affects the noradrenaline sensitivity in isolated portal vein of normotensive rat.Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.
P2860
Q24298708-DE931686-B119-4A4A-9B5C-2EA8D5104F97Q28279771-531B938A-71F6-4235-B3F1-15D53BD4B1F2Q28361248-D954E3FE-1638-4FDA-98BC-DB346030B51AQ30433144-5A396C58-9345-43AC-ABAB-EDD941C59844Q33222309-6F85C62A-EECE-49DA-96F6-C337A1D80070Q33330598-F8153018-F93E-41DE-8DA0-A4C7106E4ECDQ33593068-9102EC37-7304-4C7C-9FF1-48810C2E3064Q33650699-5A315B67-5444-430A-8C67-33AADA211438Q33691354-9570FC02-EA1A-4C39-9DE3-F943E835FA4EQ33750365-DDA594FD-BB91-4B5B-BBD2-474243C0151EQ33850948-DA134693-1E56-4EF5-8D03-E098ABF9CF7BQ33903180-AB96B18E-0319-4F86-A1C0-0571E828D6B9Q34306932-931C7147-C631-4874-BEFA-6192F3F728F6Q34496676-D55EE865-9EC4-4AB6-8F5D-D5EB43481701Q34653312-87329F0A-A90E-4EC3-B1AA-AA27F371C0EFQ34761161-B31915CA-5FD2-410F-AB31-53E1D716C8B6Q35045808-723221F4-FF2E-426F-9A8D-E13A0A496255Q35046246-5B0BF707-2177-4944-A56E-F24DEE4C13B1Q35180359-ED3C4313-6B56-44E1-A799-F1B614440706Q35672941-D311AC0B-47E4-4BB0-816E-89A0EC71B2CDQ35747133-5ADE0F0B-571F-43C3-AA09-59ED66D45621Q36241932-939D26E3-82A2-49C8-9D45-9EF5BB8060B1Q36276106-B32020E7-D63F-43F0-B0C7-010FA9E799D4Q36741895-6F89FBCE-F019-4E94-A7CD-FF213B73A6C4Q36941825-5678A61A-D5DC-4ED9-931F-C7C069C75225Q37033868-AB556889-2B8D-4C2B-8B4E-0ABD2D94D82BQ37056105-04A439FA-4AE0-4432-8217-492DFF194749Q37278552-319C25BD-ABFD-458B-9C12-502074C5B302Q37290038-84CF835E-EE0A-43C7-8C6F-A715800A3DFEQ37324997-CF2CC834-5C7B-4D23-9582-90E26CFB589FQ37329566-4B879A2C-D20B-4524-97E6-8EF4687E7ED5Q37358654-8E8497C1-D7C2-416F-8CDE-C3A781844752Q37919091-DD4B6850-6689-45FB-8A29-62DE8C69283EQ38678102-C4944251-5125-4A2A-901D-34C3BAF59749Q38879033-5AF9DCBB-71A7-455E-A5D7-152C73CBC05BQ40536187-37E085FE-9CEE-43DC-B0B3-FB17737EDB8AQ41361557-E1E3ECBB-A8DE-4458-8C73-8E7AB8917A6AQ43599143-E5D72F61-511A-4C89-A73C-801AB2730739Q43907232-FAA18B60-082C-4888-84C2-E807CC8AF547Q43976703-7C3151D1-18F4-407C-8284-F2F300460A7F
P2860
Angiotensin receptors and their therapeutic implications.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Angiotensin receptors and their therapeutic implications.
@en
type
label
Angiotensin receptors and their therapeutic implications.
@en
prefLabel
Angiotensin receptors and their therapeutic implications.
@en
P2093
P1476
Angiotensin receptors and their therapeutic implications.
@en
P2093
Alexander RW
Griendling KK
Lassègue B
P304
P356
10.1146/ANNUREV.PA.36.040196.001433
P577
1996-01-01T00:00:00Z